Contemporary management of patients with heart failure

1993, Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarctions with clinical evidence of heart failure, Lancet, 324, 821 Amidon, 1994, Is there a role for positive inotropic agents in congestive heart failure Focus on mortality, Clin Cardiol, 17, 641, 10.1002/clc.4960171203 Baker, 1994, Management of heart failure I, Pharmacologic treatment. JAMA, 272, 1361 Baker, 1994, Management of heart failure III, The role of revascularization in the treatment of patients with moderate or severe left ventricular systolic dysfunction. JAMA, 272, 1528 Baker, 1994, Management of heart failure IV, Anticoagulation for patients with heart failure due to left ventricular systolic dysfunction. JAMA, 272, 1614 Braunwald, 1991, ACE inhibitors-a cornerstone of the treatment of heart failure, N Engl J Med, 325, 351, 10.1056/NEJM199108013250508 Cohn, 1992, The prevention of heart failure-a new agenda, N Engl J Med, 327, 725, 10.1056/NEJM199209033271010 Cohn, 1986, Effects of vasodilator therapy on mortality in chronic congestive heart failure Results of a Veterans Administration Cooperative Study, N Engl J Med, 314, 1547, 10.1056/NEJM198606123142404 Cohn, 1991, A comparison of enalapril with hydralazine- isosorbide dinitrate in the treatment of chronic congestive heart failure, N Engl J Med, 325, 303, 10.1056/NEJM199108013250502 1987, Effects of enalapril on mortality in severe congestive heart failure, N Engl J Med, 316, 1429, 10.1056/NEJM198706043162301 Deedwania, 1993, Secondary prevention after myocardial infarction Too many choices, which ones work?, Arch Intern Med, 153, 285, 10.1001/archinte.1993.00410030005001 Doral, 1994, Randomized trial of low-dose amiodarone in severe congestive heart failure, Lancet, 344, 493, 10.1016/S0140-6736(94)91895-3 Dracup, 1994, Management of heart failure II, Counseling, education, and lifestyle modifications. JAMA, 272, 1442 Epstein, 1993, Mortality following ventricular arrhythmia suppression by encainide, flecainide and morizicine after myocardial infarction, J Am Coll Cardiol, 270, 2451 Feldman, 1993, Effects of vesnarinone on morbidity and mortality in patients with heart failure, N Engl J Med, 329, 149, 10.1056/NEJM199307153290301 Ghali, 1990, Trends in hospitalization rates for heart failure in the United States 1973-1986, Arch Intern Med, 150, 769, 10.1001/archinte.1990.00390160043010 Gheorghiade, 1993, Predicting clinical deterioration after digoxin withdrawal in heart failure Insights from the PROVED and RADIANCE trials, Eur Heart J, 14, 198 Goldbourt, 1993, Early administration of nifedipine in suspected acute myocardial infarction, Arch Intern Med, 153, 345, 10.1001/archinte.1993.00410030053008 1994, Sporavvivenza nellTnfarto Miocardico GISSI-3 Effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6- week mortality and ventricular function after acute myocardial infarction, Lancet, 343, 1115 1989, The Secondary Prevention Israeli Nifedipine Trial (SPRINT): A randomized intervention trial of nifedipine in patients with acute myocardial infarction, Eur Heart J, 9, 354 Jessup, 1989, Angiotensin-converting enzyme inhibitors Are there significant clinical differences? [edit], J Am Coll Cardiol, 13, 1248, 10.1016/0735-1097(89)90295-7 Konstam, 1994, Heart failure Evaluation and care of patients with left ventricular systolic dysfunction Konstam, 1993, Effects of the angiotensin converting enzyme inhibitor enalapril on long-term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction, Circulation, 88, 2277, 10.1161/01.CIR.88.5.2277 Lonn, 1994, Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection, Circulation, 90, 2056, 10.1161/01.CIR.90.4.2056 1988, The effect of diltiazem on mortality and reinfarction after myocardial infarction, N Engl J Med, 319, 385, 10.1056/NEJM198808183190701 Packer, 1991, The effect of oral milrinone on mortality in severe chronic heart failure, N Engl J Med, 325, 1468, 10.1056/NEJM199111213252103 Packer, 1993, Withdrawal of digoxin from patients with chronic heart failure treated with angioten- sin-converting-enzyme inhibitors, N Engl J Med, 329, 1, 10.1056/NEJM199307013290101 Parmley, 1994, Clinical practice guidelines Does the cookbook have enough recipes?, JAMA, 272, 1374, 10.1001/jama.1994.03520170084042 Pfeffer, 1992, Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction, N Engl J Med, 327, 668, 10.1056/NEJM199209033271001 Pfeffer, 1988, Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction, N Engl J Med, 319, 80, 10.1056/NEJM198807143190204 Pitt, 1991, Angiotensin-converting inhibitors in patients with congestive heart failure A class effect?, Am J Cardiol, 68, 106, 10.1016/0002-9149(91)90720-6 Pitt, 1994, Use of “Xapril” in patients with chronic heart failure A paradigm or epitaph for our times?, Circulation, 90, 1550, 10.1161/01.CIR.90.3.1550 Pouleur, 1991, Difference in mortality between patients treated with captopril or enalapril in the xamoterol in severe heart failure study, Am J Cardiol, 68, 71, 10.1016/0002-9149(91)90713-U Pratt, 1989, The inverse relationship between baseline left ventricular ejection fraction and outcome of antiarrhythmic therapy A dangerous imbalance in the risk-benefit ratio, Am Heart J, 118, 433, 10.1016/0002-8703(89)90254-8 Schocken, 1992, Prevalence and mortality rate of congestive heart failure in the United States, J Am Coll Cardiol, 20, 301, 10.1016/0735-1097(92)90094-4 Silver, 1994, A clinical rule to predict preserved left ventricular ejection fraction in patients after myocardial infarction, Ann Intern Med, 121, 750, 10.7326/0003-4819-121-10-199411150-00004 1991, Effects of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure, N Engl J Med, 325, 293, 10.1056/NEJM199108013250501 1992, Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions, N Engl J Med, 327, 685, 10.1056/NEJM199209033271003 Uretsky, 1993, Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure Results of the PROVED Trial, J Am Coll Cardiol, 22, 955, 10.1016/0735-1097(93)90403-N Vinson, 1990, Early readmission of elderly patients with congestive heart failure, J Am Geriatr Soc, 38, 1290, 10.1111/j.1532-5415.1990.tb03450.x 1990, Heart Failure Study Group Xamoterol in severe heart failure, Lancet, 336, 1, 10.1016/0140-6736(90)91517-E Young, 1993, ventricular remodelling and the renin-angiotensin system Insights from recently completed clinical trials, Eur Heart J, 14, 14, 10.1093/eurheartj/14.suppl_C.14 Young, 1994, Angiotensin-converting enzyme inhibitors in heart failure New strategies justified by recent clinical trials, Int J Cardiol, 43, 151, 10.1016/0167-5273(94)90004-3 Young, 1994, Asymptomatic left ventricular dysfunction To treat or not to treat?, J Heart Lung Transplant, 13, 135 Young, 1994, The diagnostic evaluation of patients with heart failure, 597 Young, 1993, Are low serum levels of digoxin effective in chronic heart failure? Evidence challenging the accepted guidelines for a therapeutic serum level of the drug, American College of Cardiology 42nd Annual Scientific Session. J Am Coll Cardiol, 21, 378A Young, 1986, Heart failure, 151 Young, 1994, Patterns of medication use in patients with heart failure A report from the Registry of Studies of Left Ventricular Dysfunction (SOLVD), South Med J, 88, 514, 10.1097/00007611-199505000-00002 Yusuf, 1993, Effect of angiotensin-converting enzyme inhibitors in left ventricular dysfunction in the context of other similar trials, J Cardiovasc Pharmacol, 22, S28, 10.1097/00005344-199312002-00007 Zusman, 1993, Angiotensin-converting enzyme inhibitors More different than alike? Focus on cardiac performance, Am J Cardiol, 72, 25H, 10.1016/0002-9149(93)91052-J